Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HDGFL2 cryptic proteins report presence of TDP-43 pathology in neurodegenerative diseases

27 Mar 2024

Abstract excerpt

This letter demonstrates the potential of novel cryptic proteins resulting from TAR DNA-binding protein 43 (TDP-43) dysfunction as markers of TDP-43 pathology in neurodegenerative diseases.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyotrophic Lateral Sclerosis Research
Share to Hereditary Neurological Disorders
Share to Neurogenetic and Muscular Disorders Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38539264
DOI: 10.1186/s13024-024-00718-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HDGFL2 cryptic proteins report presence of TDP-43 pathology in neurodegenerative diseasesPMID 38539264Read ↗

TAR DNA-binding protein 43 in neurodegenerative diseaseSemantic proximity Read ↗

Decoding TDP-43: the molecular chameleon of neurodegenerative diseasesSemantic proximity Read ↗

An ALS-associated TARDBP mutation drives cryptic exon inclusion and RNA dysregulationSemantic proximity Read ↗

Implications of TDP-43 in non-neuronal systemsSemantic proximity Read ↗

Light Chain Neurofilament to HDGFL2 cryptic peptide ratio as a fluid biomarker to monitor TDP-43 dysfunction in ALS and FTDSemantic proximity Read ↗

TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathiesSemantic proximity Read ↗

Sensitivity to TDP-43 loss and degradation resistance determine cryptic exon biomarker potentialSemantic proximity Read ↗

The era of cryptic exons: implications for ALS-FTDSemantic proximity Read ↗

TDP-43-negative FTLD-U is a significant new clinico-pathological subtype of FTLDSemantic proximity Read ↗

Reappraisal of TDP-43 pathology in FTLD-U subtypesSemantic proximity Read ↗

Biomarkers for diseases with TDP-43 pathologySemantic proximity Read ↗

TDP-43: an emerging new player in neurodegenerative diseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.